Letter by Xie et al Regarding Article, “Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease: Results From the LEADER Trial”
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.